

It appears more likely that the federal government, including FDA, will face a 10/1 shutdown due to a Congressional impasse to approve an appropriations bill for fiscal year 2024.

Human Drugs
FDA Releases Novo Nordisk FDA-483
FDA releases a two-item Form FDA-483 citing GMP issues documented at Novo Nordisk’s Clayton, NC facility during a 7/6-13 inspection.